346 related articles for article (PubMed ID: 19390303)
21. Primary chemotherapy in epithelial ovarian cancer.
Hurwitz HI; McGuire WP
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):141-54. PubMed ID: 7912423
[TBL] [Abstract][Full Text] [Related]
22. Intraperitoneal therapy of ovarian cancer.
Markman M
Semin Oncol; 1998 Jun; 25(3):356-60. PubMed ID: 9633848
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal Therapy of Ovarian Cancer.
Markman M
Oncologist; 1996; 1(1 & 2):18-21. PubMed ID: 10387964
[TBL] [Abstract][Full Text] [Related]
24. Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?
Markman M
Gynecol Oncol; 1993 Oct; 51(1):86-9. PubMed ID: 8244180
[TBL] [Abstract][Full Text] [Related]
25. Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer.
Oestreicher P
ONS Connect; 2007 Apr; 22(4):24-5. PubMed ID: 17477008
[No Abstract] [Full Text] [Related]
26. Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA; Berek JS
Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
[TBL] [Abstract][Full Text] [Related]
27. [Intraperitoneal cisplatin chemotherapy for ovarian cancer].
Hayashi H; Nishii H; Ueda K; Kunitou S; Wada S; Takanashi H; Kobayashi S; Yasuda M
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2043-8. PubMed ID: 11791382
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer.
Fujiwara K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():354-8. PubMed ID: 10895180
[No Abstract] [Full Text] [Related]
29. Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma.
Markman M
Semin Oncol; 1989 Aug; 16(4 Suppl 6):79-82. PubMed ID: 2669140
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal chemotherapy in the management of malignant disease.
Markman M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
Tummala MK; Alagarsamy S; McGuire WP
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1135-47. PubMed ID: 18588458
[TBL] [Abstract][Full Text] [Related]
32. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
[TBL] [Abstract][Full Text] [Related]
33. Intraperitoneal chemotherapy in ovarian cancer.
Hofstra LS; de Vries EG; Mulder NH; Willemse PH
Cancer Treat Rev; 2000 Apr; 26(2):133-43. PubMed ID: 10772970
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal chemotherapy.
Schneider JG
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):195-212. PubMed ID: 8015764
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
Sugarbaker PH
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
[TBL] [Abstract][Full Text] [Related]
36. [Effect of evidence-based medicine on the decision of chemotherapy for epithelial ovarian cancer].
Li GT
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):582-6. PubMed ID: 23141177
[No Abstract] [Full Text] [Related]
37. Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Sznurkowski J; Emerich J
Adv Med Sci; 2012 Jun; 57(1):46-50. PubMed ID: 22430042
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal chemotherapy for epithelial ovarian cancer.
Alhayki M; Hopkins L; Le T
Obstet Gynecol Surv; 2006 Aug; 61(8):529-34. PubMed ID: 16842633
[TBL] [Abstract][Full Text] [Related]
39. [Intraperitoneal chemotherapy for ovarian cancer].
Noma J; Yoshida N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
[TBL] [Abstract][Full Text] [Related]
40. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
